Articles On Oncosil Medical (ASX:OSL)

Title Source Codes Date
Top 10 at 10: Check out these 42% nickel veinlets

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead OSL 5 hours ago
Closing Bell: Tech stocks in demand ahead of Tesla results; Osteopore up 130pc on clinical trial news

The ASX extends its gains on Tuesday Tech stocks rallied ahead of US megacap earnings, while goldies struggled Tesla, along with Alphabet and Spotify, will release results tonight   The ASX200 lifted on Tuesday, up by +0.45% after trackin...

Stockhead OSL 23 hours ago
Top 10 at 10: Here comes this project’s first gold drilling program in over a decade

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead OSL 5 days ago
First Turkish patient treated with OncoSil cancer treatment device

Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has announced the first treatment utilising the OncoSil device on a patient residing in Turkey.

BiotechDispatch OSL 1 week ago
Top 10 at 10: Piedmont gets green light to build ‘one of the lowest cost, most sustainable lithium hydroxide operations in the world’

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead OSL 1 week ago
OncoSil doses first patient with OncoSilTM to advance pancreatic cancer treatment trials

OncoSil Medical (ASX:OSL), in its ongoing mission to develop treatments for pancreatic cancer, says the first patient treatment using the OncoSilTM device for its TRIPP-FXX clinical study has been conducted at the prestigious Hammersmith Ho...

themarketonline.com.au OSL 1 week ago
Closing Bell: Gains in Gold and Tech stocks offset by losses in Energy as oil price retreats

The ASX200 closed up slightly by +0.1% on Monday as gains in tech and gold stocks were offset by losses in the energy sector.  Energy stocks struggled as crude prices fell more than US$1 a barrel in Asian hours today after Israel confirmed...

Stockhead OSL 2 weeks ago
Market close: ASX slips with IT seeing out the week in headwinds

The ASX200 has closed down .56 of a per cent with IT down 1.4 per cent and in the red for a second straight day, materials slumping 0.8 per cent and real estate shedding .61 per cent. Coming into sharp focus today were OncoSil Medical, T...

themarketonline.com.au OSL 2 weeks ago
Market update: ASX edges down with energy bouyant in a sea of red

The ASX200 is down nearly .7 of a per cent – almost on par with futures’ predictions – with most sectors, apart from energy, in the red. The Australian Bureau of Statistics released data showing that imported goods rose by 4.8 per cent i...

themarketonline.com.au OSL 2 weeks ago
OncoSil Medical doses patients in Austria and expands worldwide

OncoSil Medical (ASX:OSL) – on its mission to combat pancreatic cancer – has now dosed the first two patients in Austria with the use of the OncoSilTM device. In early trade Oncosil shares catapulted as much as 30 per cent after announci...

themarketonline.com.au OSL 2 weeks ago
Closing Bell: ASX too timid on Tuesday. Although Dart Mining has a decent Mesoblast

The ASX200 ends Tuesday slightly lower Resources stocks hold the fort, everyone else AWOL  Small Caps led by Dart Mining and Mesoblast   Local stocks looked the goods during the first hour of the new quarter, but that – like the ASX200’s...

Stockhead OSL 3 weeks ago
Top 10 at 11: Little diggers turn up value as lithium, gold finds continue

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead OSL 4 weeks ago
Closing Bell: ASX loses its bottle, but Gold50 shows some Gallium to advance 50pc

The ASX200 has ended Friday down 0.15pc, but ends week higher Property and Healthcare gains offset by Resources losses  Small Caps led by Gold50   Wall Street hit more record highs on Thursday in New York, the Australian market on Friday,...

Stockhead OSL 1 month ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead OSL 1 month ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead OSL 1 month ago
Closing Bell: ASX200 flat and earthbound as Nyrada CEO exclusively shares 3 reasons for stunning 420pc session

  Local markets end hopelessly, slightly lower IT sector surges 2.9%   Small Caps led by incredible Nyrada outperformance   Despite a return to form for lithium and a stunning 420% rally for little local drugmaker Nyrada, the ASX200 was t...

Stockhead OSL 1 month ago
Closing Bell: The ASX has come a long way and gone nowhere on Monday

  Local markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for Energy Small Caps led by Enova Mining   Australian sharemarkets lacked all the vim, vigour and vinegar one associates with victory on Mond...

Stockhead OSL 1 month ago
Closing Bell: Aussie benchmark fails Tuesday pub test. We should all be there now

  Local markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat   The ASX200 has ended a second slumbrous session slightly lower, with a little dribble in the shape of the Star Casino at the corner of its mouth. US M...

Stockhead OSL 2 months ago
Closing Bell: Material gains for the ASX on Friday while a good week at work sees Tech Sector gain 7.5pc

ASX adds 0.7pc to close out the week in a positive frame of mind IT and materials rise, thanks to a softening US dollar and general commodity weirdness Small caps led by NKOTB, Australian Wealth Advisors Group on a solid debut   Materi...

Stockhead OSL 2 months ago
Closing Bell: ASX embraces Star Tech and Return of the Jobless

ASX rises 0.77pc, hefted heavenward with the help of a huge tech buy InfoTech was the best of the sectors, up 6.81pc by day’s end Small cap winners included James Bay Minerals, Bellavista Resources and Way2VAT   Local markets have stru...

Stockhead OSL 2 months ago
Top 10 at 11: Lithium hits and AI are what’s driving the news today

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead OSL 2 months ago
Market Highlights: Dovish comments from Fed, gold nears all-time high, and 5 ASX small caps to watch

ASX to gain on Wednesday after dovish comments from US Fed Gold price continues to climb, nears all time high Deutsche Bank is positive about equities’ prospects in 2024   Aussie shares are poised to edge higher again on Wednesday after m...

Stockhead OSL 4 months ago
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads

ASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing Allegra’s Spinal Cage Device made from 3D-printed Sr-HT-Gahnite Stockhead reached out to Allegra’s board member, Dr Nick Hartnell   It’s b...

Stockhead OSL 5 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead OSL 5 months ago
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance

The ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Small caps led by 4DX, Infinity and a few Lake Johnston lithium plays   The local market is back to digging its little hole from which it may t...

Stockhead OSL 5 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead OSL 6 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead OSL 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead OSL 7 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead OSL 7 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead OSL 7 months ago
Closing Bell: ASX200 makes it a hat-trick after Tech Sector triumph

ASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivity  Miners lead small cap gains, ERW, RDN, AZS winning at home in Andover South   The Australian share market was up and about early on Thur...

Stockhead OSL 7 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead OSL 8 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead OSL 8 months ago
OncoSil Medical (ASX:OSL) gains ethics committee approval for PANCOSIL trial

OncoSil Medical (OSL) gains ethics committee approval for its PANCOSIL trial, focused on treating patients with locally advanced pancreatic cancer (LAPC) The company will recruit 15 patients for treatment using its OncoSil device via a p...

themarketherald.com.au OSL 10 months ago
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs

OncoSil gets Ethics committee approval Starpharma’s  nasal spray VIRALEZE granted approval in Malaysia Botanix Pharmaceuticals strikes deal in Korea   Medical device OncoSil Medical (ASX:OSL) rose 8% this morning after the Ethics committe...

Stockhead OSL 10 months ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead OSL 10 months ago
CLOSING BELL: Someone please give the market a nudge… I think it’s fallen asleep

The ASX fell this morning and – sadly – just never recovered. It’s down 0.64%. Aside from Happy Times among the lithium players, it’s been a total snoozefest Rubix Resources (ASX:RB6) takes bragging rights with a 41.6% hike for the day  ...

Stockhead OSL 10 months ago
Oncosil Medical announces first patient treatment in Italy

OncoSil Medical (ASX:OSL) has announced the first patient treatment in Italy with its OncoSil device.

BiotechDispatch OSL 11 months ago
OncoSil Medical (ASX:OSL) treats first patient in Italy with flagship device

OncoSil Medical (OSL) treats its first patient in Italy with the Oncosil device, its flagship product for pancreatic cancer treatment The first patient treatment was carried out at the San Camilo-Forlanini Hospital in Rome, a significant...

themarketherald.com.au OSL 11 months ago
TMH Spotlight: OncoSil Medical (ASX:OSL) treats first patient in Italy, Iceni Gold (ASX:ICL) strikes high grade gold at Guyer

The ASX opened lower this morning, while majority of the sectors dragged. Finance and communications fell 0.5 per cent, while healthcare also took a hit – down 0.13 per cent. However, Amplia Therapeutics (ATX) appeared immune to the...

themarketherald.com.au OSL 11 months ago
Closing Bell: Its a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

Stockhead OSL 11 months ago
Oncosil Medical (ASX:OSL) enrols first patient in its new clinical study for pancreatic cancer

OncoSil Medical (OSL) enrols the first patient into its randomised clinical study of its namesake OncoSil device to be used in combination with Folfirinox chemotherapy OSL plans to recruit 80 patients across 15 hospital sites in the UK a...

themarketherald.com.au OSL 11 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead OSL 11 months ago
OncoSil announces new presentation of clinical outcomes data

Medical device company OncoSil (ASX:OSL) has announced the findings of an oral presentation at The Mayo Clinic IMPACT Course 2023 by Dr Frank Weilert from Waikato Hospital in New Zealand.

BiotechDispatch OSL 11 months ago
CLOSING BELL: Despite another charge on gold, the ASX has limped to a -0.08% close

ASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners again, up 1.96% and well ahead of the market Mt Monger does well with a 23% gain to be over +130% for the month   After an early grimace-indu...

Stockhead OSL 11 months ago
CLOSING BELL: Iron ore price plunge leads the ASX lower, leaving REEs to rule the roost

ASX 200 benchmark closes 0.11% lower after a fickle day on the bourse Iron ore price drops to five month lows, making (almost) everyone sad Larvotto ends up on top of the Small Caps, adding 61.9% for the day   Aussie markets were a tad me...

Stockhead OSL 11 months ago
OncoSil Medical (ASX:OSL) further commercial milestones achieved in Spain

OncoSil Medical (OSL) makes further commercial progress in Spain with its namesake OncoSil brachytherapy device for the treatment of pancreatic cancer The company says the first patient treated with OncoSil in Spain has undergone success...

themarketherald.com.au OSL 1 year ago
Top 10 at 10: A couple of oil and gas, lithium discoveries to get excited about

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead OSL 1 year ago
CLOSING BELL: Please secure your own oxygen mask first before assisting others

ASX down, then up, then down even further to -1.4% as bank crisis looms large. XEC Emerging Companies index plummets 1.8% as fear overtakes greed. Goldies are making hay again, XED All Ordinaries Gold up more than 7.0%.   Things have been...

Stockhead OSL 1 year ago
Top 10 at 10: Offtake deals, spectacular metal grades and lucrative takeovers

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead OSL 1 year ago